Kingfa Medical has broken through technical barriers in NC membrane production, achieving domestic substitution with its self-developed nitrocellulose membrane. Featuring international advanced standards in uniformity and long-term stability, the membrane offers high protein binding capacity, a uniform microporous structure, and strict quality control ensuring batch-to-batch consistency. This innovation provides reliable solutions for immunodiagnostic reagents, bolstering domestic IVD competitiveness in the global market.